€25.76
1.45% today
Helsinki, Feb 28, 04:53 pm CET
ISIN
FI0009010912
Symbol
REG1V
Sector

Revenio Group Stock price

€26.14
-3.88 12.92% 1M
-6.54 20.01% 6M
-0.44 1.66% YTD
-0.36 1.36% 1Y
-17.20 39.69% 3Y
-1.21 4.42% 5Y
+19.38 286.69% 10Y
Helsinki, Closing price Thu, Feb 27 2025
-0.50 1.88%
ISIN
FI0009010912
Symbol
REG1V
Sector

Key metrics

Market capitalization €695.24m
Enterprise Value €688.44m
P/E (TTM) P/E ratio 37.64
EV/FCF (TTM) EV/FCF 30.33
EV/Sales (TTM) EV/Sales 6.66
P/S ratio (TTM) P/S ratio 6.72
P/B ratio (TTM) P/B ratio 6.46
Dividend yield 1.45%
Last dividend (FY23) €0.38
Revenue growth (TTM) Revenue growth 7.04%
Revenue (TTM) Revenue €103.40m
EBIT (operating result TTM) EBIT €25.00m
Free Cash Flow (TTM) Free Cash Flow €22.70m
Cash position €20.70m
EPS (TTM) EPS €0.69
P/E forward 29.82
P/S forward 6.01
EV/Sales forward 5.95
Show more

Is Revenio Group a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

Revenio Group Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Revenio Group forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Revenio Group forecast:

Buy
86%
Hold
14%

Financial data from Revenio Group

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
103 103
7% 7%
100%
- Direct Costs 59 59
15% 15%
57%
45 45
2% 2%
43%
- Selling and Administrative Expenses 15 15
213% 213%
14%
- Research and Development Expense - -
-
-
30 30
1% 1%
29%
- Depreciation and Amortization 5.20 5.20
33% 33%
5%
EBIT (Operating Income) EBIT 25 25
6% 6%
24%
Net Profit 19 19
3% 3%
18%

In millions EUR.

Don't miss a Thing! We will send you all news about Revenio Group directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Revenio Group Oyj engages in ophthalmic diagnostics and the manufacture and sale of ophthalmic devices. The firm's ophthalmic diagnostic solutions include intraocular pressure measurement devices under the iCare brand, retinal imaging devices, and perimeters. The company was founded in 2001 and is headquartered in Vantaa, Finland.

Head office Finland
CEO Jouni Toijala
Employees 241
Founded 2001
Website www.reveniogroup.fi

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today